Patents by Inventor Johnny Y. Nagasawa

Johnny Y. Nagasawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HSD17B13 INHIBITORS AND USES THEREOF
    Publication number: 20240083861
    Abstract: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
    Type: Application
    Filed: September 29, 2021
    Publication date: March 14, 2024
    Inventors: Andrew R. Hudson, Steven P. Govek, Johnny Y. Nagasawa, Iriny Botrous, Nicholas D. Smith, Karensa L. Fasanya
  • HSD17B13 INHIBITORS AND USES THEREOF
    Publication number: 20240034736
    Abstract: Described herein are compounds that are HSD17B13 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with HSD17B13 activity.
    Type: Application
    Filed: September 29, 2021
    Publication date: February 1, 2024
    Inventors: Andrew R. Hudson, Steven P. Govek, Johnny Y. Nagasawa, Iriny Botrous, Nicholas D. Smith, Karensa L. Fasanya
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220089575
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 24, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Karensa L. DOUGLAS, Andiliy G. LAI
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220081390
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 17, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20220056019
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: September 17, 2019
    Publication date: February 24, 2022
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI, Karensa L. DOUGLAS
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11236071
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: February 1, 2022
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa, Karensa L. Douglas, Andiliy G. Lai
  • SSAO INHIBITORS AND USES THEREOF
    Publication number: 20220002309
    Abstract: Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.
    Type: Application
    Filed: October 23, 2019
    Publication date: January 6, 2022
    Inventors: Nicholas D. SMITH, Andrew R. HUDSON, Mi CHEN, Johnny Y. NAGASAWA, Iriny BOTROUS
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 11214538
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: January 4, 2022
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20210300875
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: January 19, 2021
    Publication date: September 30, 2021
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10961198
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 30, 2021
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10927082
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: February 23, 2021
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Stephen P. Govek, Johnny Y. Nagasawa
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20210032195
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: May 12, 2020
    Publication date: February 4, 2021
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200290973
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventors: Nicholas D. SMITH, Stephen P. GOVEK, Johnny Y. NAGASAWA
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10703712
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: July 7, 2020
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
  • SSAO INHIBITORS AND USES THEREOF
    Publication number: 20200181104
    Abstract: Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Nicholas D. Smith, Andrew R. Hudson, Mi Chen, Johnny Y. Nagasawa, Iriny Botrous
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131129
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131142
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Karensa L. Douglas
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131134
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20200131132
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Application
    Filed: March 14, 2018
    Publication date: April 30, 2020
    Inventors: Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
  • Farnesoid X receptor agonists and uses thereof
    Patent number: 10626081
    Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: April 21, 2020
    Assignee: METACRINE, INC.
    Inventors: Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa